Factors and complications affecting catheter and technique survival with permanent single-lumen dialysis catheters

Meester, Johan De; Vanholder, Raymond; Roose, J. De; Ringoir, S

doi:10.1093/ndt/9.6.678

Cited by 49 publications

(19 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies showing that TCath was the best vascular access option to treat refractory nection, and also be careful in handling catheters; second, the patient must be aware of the crucial role congestive heart failure on a long-term basis by ultrafiltration confirmed this potential interest [31]. of hygiene in reducing the bacterial contamination level of the skin [22,23]. It is also interesting to note TCath performances were adapted to deliver an adequate dialysis dose with a conventional short treatthat TCaths not anchored to the subcutaneous tunnel with a dacron cuff had better survival than cuffed ment schedule.…”

Section: Discussionmentioning

confidence: 99%

Permanent twin catheter: a vascular access option of choice for haemodialysis in the elderly patients

Canaud¹,

Leray‐Moragues²,

Garrigues³

et al. 1998

Nephrology Dialysis Transplantation

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Permanent twin catheter: a vascular access option of choice for haemodialysis in the elderly patients

Canaud¹,

Leray‐Moragues²,

Garrigues³

et al. 1998

Nephrology Dialysis Transplantation

View full text Add to dashboard Cite

“…This meta-analysis of internal jugular TDC-related bacteremia rates was based on data published in 15 articles that met the following criteria: prospective studies, including prospective cohort and randomized controlled trials of tunneled, cuffed catheters with at least 20 patients. [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] Studies of the LifeSite Hemodialysis Access System (Vasca Inc, Tewksbury, Mass) and Dialock Access System (Biolink Inc, Norwell, Mass) were excluded. The final normalized cumulative TDC bacteremia control rate was 2.3/1000 catheter days.…”

Section: Methodsmentioning

confidence: 99%

Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients

Katzman

McLafferty

Ross

et al. 2009

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…The longer survival rate published was by Tesio et al [6] with cuffed TC with a 1-year survival rate of 93% after exclusion of catheters lasting less than 1 month. For others, with the single lumen catheter, the 1-year technical patency was 80%, the left side being characterized by a lower survival rate [26]. For Moss et al [7], among 168 cuffed silicone catheters, the median survival was 550 days and 1-year survival was 65%.…”

Section: Infectionmentioning

confidence: 97%

Long-Term Outcome of Permanent Hemodialysis Catheters: A Controlled Study

Gadrey¹,

Charra²,

Chazot³

et al. 2001

Blood Purif

View full text Add to dashboard Cite

Aims: Hemodialysis tunneled catheters are widely used nowadays. However, their complications, infection and dysfunction, remain much too frequent. Different types of tunneled silicone hemodialysis catheters are available. We prospectively compared the long-term outcome of the two most popular devices, Permcath cuffed double catheter and TwinCath uncuffed twin catheter, both inserted percutaneously. Methods: From January 1994 to April 1998, 125 tunneled catheters were inserted in the internal jugular vein of 86 chronic hemodialysis patients, 63 TwinCath MedComp^® (TC) and 62 Permcath Quinton^® (PC). They were prospectively followed looking for technical patency, infection and dysfunction rate. Results: TC were used more often for iterative access (52 vs. 25% , p = 0.01) and were inserted more frequently in the left internal jugular vein (59 vs. 16% p < 0.001). Their median technical survival rate was longer (869 vs. 433 days for PC, p < 0.01) with a 1-year patency rate of 80 vs. 53% (p = 0.002). Total catheter extrusion was also slightly less frequent with TC (4.7 vs. 9.6%), but partial extrusion happened more frequently (43 vs. 16%, p = 0.02). No significant difference in infection rate was observed, 0.77 for TC vs. 1.3 local infection/1,000 catheter days; 1.08 vs. 1.30 bacteremia/1,000 catheter days. A persistent catheter thrombosis was observed in 7.9 vs. 20.9% in PC (p = 0.04), the number of dysfunction was 10.5 vs. 24/1,000 days in use (p = 0.0001) and the number of urokinase infusion was 4.4 vs. 12/1,000 days (p = 0.001). PC needed more radiological interventions for dysfunction with endolumenal brushes (4 vs. 0) or fibrin sleeve removal (4 vs. 0). The vena cava thrombosis incidence was not different (2 vs. 3). Conclusion: Although the study was not randomized, TC appears more efficient allowing for a longer patency with a lower dysfunction rate than PC. This was reinforced by less favorable conditions of TC including more left jugular side and more iterative catheters. The cuff does not offer a better bacteriological barrier or protection against extrusion, and the TC seems at a less risk of fibrin sleeves. However, a large randomized study is needed to definitively conclude.

show abstract

Factors and complications affecting catheter and technique survival with permanent single-lumen dialysis catheters

Cited by 49 publications

References 0 publications

Permanent twin catheter: a vascular access option of choice for haemodialysis in the elderly patients

Permanent twin catheter: a vascular access option of choice for haemodialysis in the elderly patients

Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients

Long-Term Outcome of Permanent Hemodialysis Catheters: A Controlled Study

Contact Info

Product

Resources

About